Multiple myeloma | Nature Reviews Disease Primers
Multiple myeloma - The Lancet
Vincent Rajkumar on Twitter: "Note that 90% of patients with MGUS will never get myeloma or related disorder. @NEJM @MayoClinic https://t.co/Ko6EUZOKnD" / Twitter
MGUS Clinical Trials
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Screening for Monoclonal Gammopathy of Undetermined Significance: First Results from the iStopMM Study
MGUS Clinical Trials
Vincent Rajkumar on Twitter: "Here is the management approach to MGUS. Uncomplicated patients with low risk MGUS do not need a baseline bone marrow or bone survey, and don't need annual follow
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders | American Society of Clinical Oncology Educational Book
What Are MGUS, Smoldering and Active Myeloma? | The IMF
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders | American Society of Clinical Oncology Educational Book
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
Demographic and clinical data (mean values) for patients with MGUS and... | Download Table
PLOS Medicine: Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials
New IMWG Criteria Reflect Change in Practice - Clinical Oncology News
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies | Blood Cancer Journal
Meeting Library | Psychosocial effects of the relaxation response resiliency program (SMART-3RP) in patients with MGUS and smoldering multiple myeloma: A waitlist controlled randomized clinical trial.
2 Batten Disease Clinical Trials Enrolling Patients to Test Gene Therapies
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Is There a Link Between Monoclonal Gammopathy of Undetermined Significance and Familial Risk? — Diverse Health Hub
MC Community Event: Clinical Trials for High Risk Smoldering Myeloma Patients
Treatment Strategies for Patients with Multiple Myeloma: from Clinical Trials to Real Life | Frontiers Research Topic
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
Table 2 from Monoclonal gammopathy of undetermined significance. | Semantic Scholar
Multiple Myeloma Support + Trials
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
